Etoricoxib

prostaglandin-endoperoxide synthase 2 ; Homo sapiens







69 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
51 15827069 Etoricoxib: a highly selective COX-2 inhibitor. 2005 May 3
52 16049609 Analgesic efficacy of pre-operative etoricoxib for termination of pregnancy in an ambulatory centre. 2005 Aug 1
53 16054359 A general method for the synthesis of aryl [11C]methylsulfones: potential PET probes for imaging cyclooxygenase-2 expression. 2005 Oct 1 2
54 16136765 Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema. 2005 Aug 2
55 16192529 Etoricoxib provides analgesic efficacy to patients after knee or hip replacement surgery: a randomized, double-blind, placebo-controlled study. 2005 Oct 1
56 14681341 Pharmacokinetics of etoricoxib in patients with renal impairment. 2004 Jan 1
57 15319795 Etoricoxib. 2004 May 4
58 15638077 Isolation and structural characterization of the photolysis products of etoricoxib. 2004 Dec 2
59 15701208 Use of gastroprotective agents and discontinuations due to dyspepsia with the selective cyclooxygenase-2 inhibitor etoricoxib compared with non-selective NSAIDs. 2004 Dec 1
60 12534404 Complementary studies of the gastrointestinal safety of the cyclo-oxygenase-2-selective inhibitor etoricoxib. 2003 Jan 2
61 12638395 Single- and multiple-dose pharmacokinetics of etoricoxib, a selective inhibitor of cyclooxygenase-2, in man. 2003 Mar 2
62 12705971 Determination of etoricoxib in human plasma by liquid chromatography-tandem mass spectrometry with electrospray ionisation. 2003 May 25 1
63 14517196 Pharmacokinetics of etoricoxib in patients with hepatic impairment. 2003 Oct 1
64 11835200 Simultaneous determination of unlabeled and carbon-13-labeled etoricoxib, a new cyclooxygenase-2 inhibitor, in human plasma using HPLC-MS/MS. 2002 Feb 1
65 12077033 Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis. 2002 Jun 22 1
66 12180720 A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis. 2002 Aug 2
67 11160644 Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. 2001 Feb 10
68 11353749 Role of human liver cytochrome P4503A in the metabolism of etoricoxib, a novel cyclooxygenase-2 selective inhibitor. 2001 Jun 2
69 11583479 Dose proportionality of oral etoricoxib, a highly selective cyclooxygenase-2 inhibitor, in healthy volunteers. 2001 Oct 1